Basal Cell Carcinoma

Oncology·MeSH: Gallbladder Neoplasms

9 drugs in development·5 companies·6 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
Erivedge	CURIS INC (CRIS)

Phase 3(1)

Drug	Company
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(6)

Drug	Company
Cemiplimab	ADMA BIOLOGICS, INC. (ADMA)
Fianlimab	ADMA BIOLOGICS, INC. (ADMA)
part 1	Verrica Pharmaceuticals Inc. (VRCA)
part 2	Verrica Pharmaceuticals Inc. (VRCA)
suba-itraconazole bccns	Inhibitor Therapeutics, Inc. (INTI)
vp-315	Verrica Pharmaceuticals Inc. (VRCA)

Phase 4(1)

Drug	Company
Fianlimab	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 9 drugs in development for Basal Cell Carcinoma across 5 companies.

There are 6 clinical trials targeting Basal Cell Carcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.